Anti–Factor VIII–related antigen (von Willebrand factor, VWF) CE/IVD antibodies are widely used immunohistochemical (IHC) tools for the identification of endothelial lineage and vascular structures in hematopathology. Their diagnostic relevance is grounded in the well-characterized biology and tissue-specific expression of VWF, a key endothelial glycoprotein.
Biological Significance of Factor VIII–Related Antigen / VWF
Von Willebrand factor is a large multimeric glycoprotein synthesized primarily by endothelial cells and megakaryocytes and stored in endothelial Weibel–Palade bodies.
- Mediates platelet adhesion to the subendothelium and supports primary hemostasis.
- Functions as a carrier protein stabilizing coagulation factor VIII.
- Released upon endothelial activation or injury, reflecting vascular status.
- Elevated levels correlate with endothelial dysfunction and vascular pathology.
Diagnostic Utility in Hematopathology and IHC
VWF (Factor VIII–related antigen) is an established endothelial marker in histopathology.
- Demonstrates strong cytoplasmic staining in vascular endothelial cells across tissues.
- Enables identification and characterization of vascular tumors (e.g., hemangioma, angiosarcoma).
- Supports assessment of microvascular density and angiogenesis in hematologic and oncologic specimens.
- Complements other endothelial markers (CD31, CD34, ERG) in diagnostic panels.
- Useful in detecting endothelial activation, remodeling, and injury in pathological conditions.
Key Features of CE/IVD Anti-VWF Antibodies for IHC
- High specificity for endothelial differentiation, reflecting restricted expression in endothelial cells and megakaryocytes.
- Robust cytoplasmic/granular staining pattern corresponding to intracellular storage organelles (Weibel–Palade bodies).
- Compatibility with formalin-fixed, paraffin-embedded (FFPE) tissues, supporting routine clinical workflows.
- Reproducible staining across vascular beds, though sensitivity may vary compared with CD31/CD34.
- Validated for diagnostic use (CE/IVD) with optimized protocols for antigen retrieval and detection systems.
